'Scientific Innovation - Pathway to Progress in Women's Cancer' Theme
Spotlights Four Decades of Advances in Prevention and Treatment of Gynecologic Cancers
CHICAGO, Feb. 11 /PRNewswire-USNewswire/ -- The Society of Gynecologic Oncologists (SGO) will host its 39th Annual Meeting on Women's Cancer March 9-12 at the Tampa Convention Center in Tampa, Florida. The four-day educational event will feature more than 350 scientific presentations, lectures, workshops, symposium, surgical labs and postgraduate courses that focus on emerging science, clinical trials and treatment advances for physicians and health care professionals in the field of gynecologic oncology.
Long viewed as the premier educational and scientific event in the profession, this year's meeting had a record 718 research and clinical trial abstracts submitted from all over the world for consideration in the program. "We are pleased with the volume and quality of research concentrated on gynecologic cancers that emerged this year," said SGO President, Andrew Berchuck, M.D. "The ability to meet annually and learn about new advances in diagnosis, treatment and prevention modalities is vital to improving the care and outcomes for our patients battling gynecologic cancers. We want everyone to know that the science shared at this meeting does, in fact, translate into improved care."
For four decades, gynecologic oncologists have been dedicated to the
care and treatment of women's cancers including ovarian, cervical,
endometrial, vulvar and vaginal cancer. These specialists are
obstetrician/gynecologists who have received three to four years of
additional training in oncology, surgery, Chemotherapy, radiation therapy
and supportive care. Gynecologic oncologists have also been leaders in
conducting research and clinical trials to improve patient care standards,
treatment methods, and preventative and diagnostic medicine. As the
national society for these physicians, the
|SOURCE Society of Gynecologic Oncologists|
Copyright©2008 PR Newswire.
All rights reserved